The Investigator – August 2019
Brody School of Medicine Research Newsletter
Brody Brothers Endowment Awards Applications due Sept. 20
Proposals for the annual Brody Brothers Endowment Research Awards are being accepted.
Applications should focus on cancer, diabetes and obesity, cardiovascular disease or other health problems prevalent in eastern North Carolina. Applications are available via DHS Announce and the Research & Graduate Studies (bottom of the homepage).
Send applications to BSOM-research@ecu.edu by 5pm on September 20, 2019.
For additional questions, please reach out to Perrinne Wooten.
Update: eTRACS Pre-Award System
eTRACS is a new proposal routing application that will replace RAMSeS. Beginning in October 2019, all new sponsored award proposals should be routed in eTRACS. Faculty should continue to use RAMSeS until the eTRACS launch. After that, Ramses will be available for archival purposes only during a transition period. Training sessions for eTRACS approvers (Chairs and Deans) and eTRACS general users have been scheduled.
Click here for the training session schedule
Innovative Mental Health Services Research Not Involving Clinical Trials (R01)
This application is intended to foster mental health services research in strategic but under-studied areas where new knowledge has potential for high public health impact. This application supports non-clinical trials research, including quasi-experimental studies, survey or qualitative research methods, clinical epidemiology, and development and testing of new research methods, measures, or statistical approaches related to mental health services research. Health services research can target patients, providers, healthcare leaders and administrators, and/or healthcare systems or other organizations that provide services to persons with mental disorders. The National Institute of Mental Health encourages investigators to design their applications to maximize the likelihood that findings will inform future research and/or be translated rapidly into practice, whether at the patient, clinic, healthcare/other system, or policy level. Read More
Upcoming NIH Deadlines
R01(New)– October 5
R03/R21 (New)- October 16
R15 (All – new, renewal,
resubmission, revision)–
October 25
Upcoming Events:
Research Resources 101:
September 12, 2019, 1pm 2pm
Brody 2S-04
What’s under the hood in Clinical Trials?
Starting September 2019
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
The objectives of the funding opportunity announcement (FOA) are to support: (1) pharmacological studies addressing the changes in drug disposition and response among children at various developmental stages, between children and adults, and in women during pregnancy and lactation; (2) new drug development targeting children and pregnant women. This FOA boosts the current efforts of the Obstetric and Pediatric Pharmacology and Therapeutics (OPPT) Branch of the National Institute of Child Health and Human Development to provide research funding opportunities for basic, translational and clinical scientists to conduct drug research and novel drug development focusing on pediatric and obstetric populations. Read more
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
This funding announcement is looking to test innovative approaches to import diabetes and obesity prevention and/or treatment in healthcare settings where individuals receive their medical care. Research applications should be designed to test practical and sustainable strategies to improve processes of care and health outcomes for individuals with or at risk of diabetes and/or obesity. The goal of this announcement is to obtain results that will improve healthcare practice and inform healthcare policy for the prevention or management of these conditions. Hence, interventions must be integrated into the existing healthcare structure and/or processes. The healthcare setting may not be used solely as a venue for recruitment. Read More
Jessica Ellis (Physiology) received a Dementia Alliance of North Carolina award for her project entitled “Deciphering the role of DHA in the development of brain disorders.” Award total: $100,000
Beng Fuh (Pediatric Hematology/Oncology) received a contract with Novartis Pharmaceuticals for his clinical trial entitled “SEG101 (SOLACE): A phase 2, Multicenter, Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab, with or without Hydroxyurea/Hydroxycarbamide, in Sequential, Descending Age Groups of Pediatric Sickle Cell Disease Patients with Vaso-Occlusive Crisis.” Award total: $189,804
Kyle Mansfield (Biochemistry) received a Research Scholar Grant from the American Cancer Society entitled “Role of N6-methyladenosine mRNA modification in breast cancer progression.” Award total: $792,000
Stephanie Jilcott Pitts (Public Health) received an R01 from the National Institutes of Health entitled “Examining Validity and Sensitivity of Pressure-Mediated Reflection Spectroscopy as a measure of fruit and vegetable consumption in a diverse population.” Award total: $699,369
Kelsey Fisher-Wellman (ECDOI) received a Department of Defense award for his project entitled “Investigation into the Mechanisms of Acute Myeloid Leukemia (AML) Tumorigenesis and Chemoresistance via Systems Analysis of Mitochondrial Form and Function.” Award total: $590,000
CONGRATULATIONS TO BSOM FACULTY & STAFF
The Brody School of Medicine just completed a great sponsored awards fiscal year! Research awards increased from $10.0M in FY18 to $15.1M in FY19, an increase of 50%. All sponsored awards increased 89% to $30.1M.
For more information regarding school and department funding click here